Showing results (21-30 of 329) with videos related to
Sort By:
Pageof 33
Cancer Discovery|May 16, 2012
A new BATTLE in the evolving war on cancerLecia V Sequist, Alona Muzikansky, Jeffrey A EngelmanNature Reviews. Clinical Oncology|July 2, 2014
Acquired resistance to TKIs in solid tumours: learning from lung cancerD Ross Camidge, William Pao, Lecia V SequistClinical Lung Cancer|February 21, 2021
Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at ProgressionMaya N White, Zofia Piotrowska, Kevin Stirling, et al.Cancer Research|May 23, 2019
Patient-Specific Tumor Growth Trajectories Determine Persistent and Resistant Cancer Cell Populations during Treatment with Targeted TherapiesClemens Grassberger, David McClatchy, Changran Geng, et al.Nature Reviews. Clinical Oncology|May 14, 2014
Circulating tumour cells-monitoring treatment response in prostate cancerDavid T Miyamoto, Lecia V Sequist, Richard J LeeJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Genetic changes in squamous cell lung cancer: a reviewRebecca S Heist, Lecia V Sequist, Jeffrey A EngelmanAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 25, 2023
Expanding the Reach and Grasp of Lung Cancer ScreeningRaymond U Osarogiagbon, Pan-Chyr Yang, Lecia V SequistScience (New York, N.Y.)|January 25, 2024
Deploying blood-based cancer screeningDouglas S Micalizzi, Lecia V Sequist, Daniel A HaberClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2018
EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung AdenocarcinomasSusan E Jorge, Antonio R Lucena-Araujo, Hiroyuki Yasuda, et al.Nature Reviews. Clinical Oncology|May 9, 2022
Third-generation EGFR and ALK inhibitors: mechanisms of resistance and managementAlissa J Cooper, Lecia V Sequist, Jessica J LinPageof 33